Several studies assessing pulmonary artery catheter use failed to demonstrate benefit (1) (2) (3) . Consequently, the use of pulmonary artery catheters to monitor critically ill patients and to guide therapy has diminished substantially (4) . Some have suggested that the problem was not so much with the pulmonary artery catheter as with inadequate knowledge and interpretation (5) . To fulfill the perceived clinical need for similar measurements a number of new technologies have emerged, including echocardiography (6) , ultrasonic cardiac output monitors (7), arterial pulse pressure analysis techniques (8, 9) , impedance techniques (10, 11) , alternative dye dilution techniques (12) , and so on, to provide alternative/additional measurements. In the absence of clinical trials analogous to those for pulmonary artery catheters, we do not know if these alternative/additional measurements are beneficial (13) . To avoid a repeat of the pulmonary artery catheter story, it is important to maximize our knowledge of alternative/additional approaches so that we measure and interpret arising parameters in a way that maximizes clinical utility.
One remarkably simple alternative/additional measurement for which there is some evidence of clinical utility (14) (15) (16) (17) is the measurement of central venous oxygen saturation (Scv O 2 )-a surrogate measure of mixed venous oxygen saturation ( S v O2 ). Further evaluation is underway (18) (19) (20) . To maximize the clinical utility of Scv O 2 (or S v O2 ) measurement, it is useful to review what the measurement means in a physiologic context, how the measurement is made, important limitations, and how this measurement may be helpful in common clinical scenarios.
FIRST, DO WE NEED TO KNOW CARDIAC OUTPUT?
Adequate tissue oxygenation is essential for normal organ function. The amount of oxygen delivered to the tissues is flow (cardiac output in L blood/min) multiplied by oxygen-carrying capacity (mL O 2 /L blood). Thus, cardiac output is important, but is not the only factor in determining adequacy of tissue oxygenation. Metabolic demand, hemoglobin concentration, and body size are three highly variable parameters that dramatically alter the "critical cardiac output" from minute to minute, over time in the same patient, and between patients, respectively. Adequacy of tissue oxygenation is, instead, determined by the balance between oxygen delivered to tissues (DO 2 ) and oxygen consumption by the tissues (VO 2 ). This balance is reflected by the fraction of delivered oxygen that the tissues consume (ERO 2 ¼ VO 2 /DO 2 ) or by the related variable (see below) venous oxygen saturation ( S v O2 -how much of the delivered oxygen is left over after the tissues consume oxygen).
In contrast to a highly variable "critical cardiac output," many studies in many clinical states involving many different organs find a more stable and useful measurement reflecting tissue oxygenation to be the "critical oxygen extraction ratio," ERO 2 crit. Since ERO 2 ¼ VO 2 /DO 2 , when DO 2 decreases relative to VO 2 , ERO 2 increases. When DO 2 falls further (decreasing cardiac output, oxygen carrying capacity, or arterial saturation) and is inadequate to meet VO 2 demand, ERO 2 exceeds a threshold that is identified by evidence of tissue hypoxia and anaerobic metabolism, including increasing lactate production and impaired organ function. This critical threshold is ERO 2 crit. ERO 2 crit is approxmately 0.7 in normal healthy whole animals (21, 22) and regionally is approximately 0.7 in skeletal muscle (23, 24) , approximately 0.7 in gut (21, 25) , approximately 0.7 in heart (26) , and approximately 0.7 in brain (27, 28) When assessing the utility of any measurement it is important to consider the interpretation of the measurement in the face of measurement errors-related to a sensitivity analysis. For cardiac output measurement and S v O2 measurement, this can be illustrated by considering the Fick equation. Examination of this relationship ( Figure 1 ) suggests that when cardiac output is high, errors in cardiac output measurement result in only minor errors in estimates of S v O 2 ; which reflects adequacy of tissue oxygenation. However, when cardiac output is low the curve is steep (Figure 1) (29) (30) (31) (32) (33) (34) (35) (36) (37) . (Parenthetically, femoral venous blood is not mixed and not downstream of any vital organs and therefore it would be erroneous to use this value to interpret anything except oxygenation of the distal leg.) In general, a good but not perfect correlation is observed (38) (Figure 2A) Figure 2B ). Thus, when care is taken in the placement of the central venous catheter (Figure 3 ), Scv O 2 becomes a reasonable estimate of S v O2 (36, 40) .
Thus, Scv O 2 is not S v O 2 (41) , and the relationship between these two variables changes with catheter placement, between low flow and high flow states, and can clearly be influenced by relative changes in superior and inferior vena caval flow and coronary sinus flow. Thus, Scv O 2 is only an approximation of S v O 2 , and potential differences must be kept in mind when using and interpreting Scv O 2 measurements. Figure 2A illustrates these differences which, for individual measurements, can be quite discrepant.
CLINICAL USE OF S v O 2
Correct clinical interpretation of S v O 2 , or its properly measured Scv O 2 surrogate, can be used to (1) estimate cardiac output, (2) better understand a patient's physiologic state, (3) help resuscitate patients using validated treatment protocols and help identify patients at risk of weaning failure, (4) understand and treat arterial hypoxemia, and (5) rapidly estimate shunt fraction (venous admixture).
S v O 2 Can Be Used to Easily Estimate Cardiac Output Using the Fick Equation
The Fick equation can be simplified by ignoring the small contribution of dissolved oxygen and by indexing variables to body surface area. Then CI ¼ VO 2 I/{Hgb 3 1.34 3 (Sao 2 2 S v O2 )}, where CI is cardiac index (L/min/m 2 ), VO 2 I is oxygen consumption index, and 1.34 ml O 2 /gram Hgb is the amount of oxygen bound to hemoglobin and is a physical constant (theoretically 1.39 but, in practice closer to 1.34 due to a small fraction of reduced hemoglobin or carbon monoxide binding). Since VO 2 I is relatively constant at rest, Hgb is relatively constant in patients not briskly bleeding, 1.34 is a physical constant, and Sao 2 is kept relatively constant (90-100%) by typical ICU nursing protocols, the truly variable parameters in this equation are CI and S v O2 . Examination of the Fick equation shows that a decrease in S v O2 indicates a decrease in CI, and an increase in S v O2 indicates an increase in CI.
When having a rough estimate of CI is helpful in understanding the physiologic state of the circulation, this simplified Fick equation can be used at the bedside using readily available measurements. Note that the a typical resting value of VO 2 by approximately 5% could be considered but, to be clear, this is not a measurement of cardiac index; it is a "quick and dirty" approximation to aid clinical insight. When a technically correct value of cardiac output is required, then the above approximations are inappropriate (41) and direct measurements of VO 2 I and S v O2 are required.
S v O 2 Can Be Interpreted Using VO 2 /DO 2 Relationships
What is a high S v O2 value and what is a low value? S v O2 gives information regarding the balance between oxygen delivery and oxygen consumption (Figure 4 ). The onset of anaerobic metabolism is characterized by a critical oxygen extraction ratio, ERO 2 crit. In whole animal studies, in individual organ studies, and in human studies, the critical oxygen extraction ratio is approximately 70% (21) (22) (23) (24) (25) (26) (27) (28) . While relatively constant in health, ERO 2 crit decreases in a number of critical illnesses (42) that are characterized by an impaired ability of the tissues to extract oxygen; importantly including sepsis (22, 24, 25) . Impaired ability of the tissues to extract oxygen may be due to the observed increased heterogeneity of microvascular and macrovascular blood flow, related shunting of oxygen past the tissues (24, (43) (44) (45) , and impaired ability of cells and their mitochondria to utilize oxygen (46) . When tissue oxygen extraction capability is impaired, as it is during sepsis, ERO 2 crit can fall to 50% in animal studies (47) and in the human heart (48, 49) . Since S v O 2 z12ER (when arterial oxygen saturation is z 100%), it follows that the critical S v O 2 is approximately 30% in otherwise healthy individuals but can be 50% in patients who have severe sepsis or in other patients with impaired tissue oxygen extraction capability (Figure 4) . In rare patients with extreme vasodilatory shock or following mitochondrial poisoning, cardiac output can be high and S v O 2 may be very high (. 85%), yet lactate levels may be elevated and shock and organ dysfunction persist. Oxygen extraction capacity in these patients is clearly very poor-reflected by a very high S v O 2 and a correspondingly very low ERO 2 crit.
These considerations lead to an understanding of different S v O 2 values. S v O 2 over 70% generally is adequate and normal. S v O 2 less than 50% is low and, depending on tissue oxygen extraction capabilities, could be approaching values associated with ERO 2 crit. In studying the critical oxygen delivery point in dying patients, we observed that patients cannot live for much more than a few minutes to an hour below this critical threshold (42) . S v O2 less than 50% and certainly less than 40% should generally be carefully considered and acted upon. S v O 2 values between 50% and 70% are somewhat low but, by themselves, do not lead to firm conclusions and must (14) .
Scv O 2 Has Clinical Utility in Early Goal Directed Therapy and in Weaning Protocols
Although the use of Scv O 2 and S v O 2 to assess and manage patients is grounded in firm physiological principles, evidence that routine measurement of Scv O 2 affects or predicts outcomes is only emerging. Two clinical scenarios in which evidence of clinical utility of Scv O 2 has been reported are in early shock resuscitation protocols (16) and in weaning patients from mechanical ventilation (50) . Confirmation is now being tested in clinical trials.
The Surviving Sepsis Campaign Guidelines (51) endorse the elements of early goal directed therapy (EGDT) (16) protocols for resuscitation of septic shock patients. Similar physiologically targeted rapid resuscitation approaches are helpful in other shock states. The initial publication by Rivers and colleagues (16) many years ago, plus many subsequent "before/after" reports, lend evidence to support these protocols. Multiple large randomized controlled trials of EGDT and variants are now underway to more carefully test these concepts (18) (19) (20) .
S v O 2 plays a central role in EGDT and related protocols. The shared elements in all of these protocols are, first, that resuscitation should be performed in a timely manner-time is tissue. Second, volume resuscitation is a fundamental initial step and must be adequate. Third, resuscitation must achieve a reasonable mean arterial pressure so that a sufficient arterial pressure head is available to allow redistribution of the cardiac output to vital organs. Finally, after these first goals have been achieved, it is necessary to ask: is oxygen delivery adequate? In many EGDT protocols this issue is addressed by measuring Scv O 2 or S v O 2 . However, it may also be reasonable to address the same question by measuring lactate clearance (15)-same question, slightly different approach. Assessment of organ function is also important when assessing adequacy of tissue oxygenation; for example, measurement of urine output is incorporated into EGDT. An Scv O 2 greater than 70% is the original EGDT target and, as a component of River's EGDT (16) , results in a substantial reduction in mortality with a number needed to treat to prevent one death (NNT) of approximately 6 (16) . Thus, EGDT is a remarkably effective therapeutic approach and S v O 2 plays the important role of testing the final crucial question of whether oxygen delivery is adequate.
Teixeira and coworkers have recently found that among a variety of clinical parameters, Scv O 2 was the best clinical predictor of weaning failure (50) . Difficult-to-wean patients who failed a 2-hour spontaneous breathing trial were followed daily until they successfully completed the spontaneous breathing trial. Scv O 2 and a large number of standard ventilatory, blood gas, and hemodynamic variables were measured before and 30 minutes into the spontaneous breathing trial. Then patients were extubated. Only Scv O 2 (and consequently ERO 2 ) differed significantly between patients with extubation success versus extubation failure. A decrease in Scv O 2 of more than 4.5% during the spontaneous breathing trial had a sensitivity of 88% and a specificity of 95% in predicting extubation failure. Validation of these results is required.
S v O 2 Impacts Arterial Oxygenation in the Setting of Shunt/Venous Admixture
In the setting of shunt lung disease (or equivalent venous admixture through _ V/ _ Q mismatch), mixed venous oxygen saturation plays a major role in determining arterial oxygen saturation (Figure 5) . The corollary of this observation is that, in this shunt setting, therapeutic maneuvers that increase mixed venous oxygen saturation will increase arterial oxygen saturation substantially (in proportion to the degree of shunt; i.e., big shunt, big S v O 2 effect). Thus, when high FI O 2 , positive airway pressure, ventilator modes, nitric oxide, prone positioning, and other maneuvers are inadequate to achieve adequate arterial oxygenation, one more degree of therapeutic freedom is availablefocus on S v O 2 . That is, when all lung-related approaches are exhausted in treating the hypoxemic patient, increasing DO 2 (increasing cardiac output or oxygen-carrying capacity) and decreasing VO 2 (e.g., sedation, paralysis) will increase S v O 2 and, consequently, increase arterial oxygen saturation. Finally and more recently, S v O 2 can also be raised directly using extracorporeal lung support.
As a corollary, when an arterial desaturation event occurs in the setting of high shunt fraction it is important to consider, in addition to lung-related events, that a reduction in S v O 2 may contribute. A reduction in S v O 2 may occur rapidly as a result of a sudden drop in cardiac output (e.g., due to arrhythmia or other cardiac event), as a result of a decrease in venous return (e.g., due to positioning of a relatively hypovolemic patient, etc.), or as a result of an increase in oxygen consumption (e.g., due to muscle activity). Rapid spontaneous resolution of arterial oxygen saturation further increases the probability that the desaturation event was related to low S v O 2 , since the above causes are often transient. This knowledge may help detect the cause and prevent recurrence. When a desaturation event occurs in the setting of low shunt fraction, then a contribution by S v O 2 is less likely and the desaturation event is more often lung-related. Mucous plug, aspiration, FI O 2 regulation, endotracheal tube patency, ventilator circuit malfunction, pneumothorax, and so on become more likely explanations.
This line of reasoning helps quickly diagnose and treat desaturation events, but depends upon a prior knowledge of shunt fraction. How can shunt fraction be often and easily estimated so that it is part of routine critical care practice?
S v O 2 Can Be Used to Quickly Estimate Shunt Fraction
The equation for shunt fraction is:
where Cco 2 is the oxygen concentration in maximally saturated pulmonary end-capillary blood (i.e., Sco 2 ¼ 1). Ignoring dissolved oxygen, this can be simplified to:
For example, when pulse oximeter oxygen saturation is 90% and S v O 2 is 60%, the shunt fraction is (1 2 0.9)/(1 2 0.6) ¼ 25%, or when pulse oximeter oxygen saturation is 85% and S v O2 is 70%, the shunt fraction is (1 2 0.85)/(1 2 0.7) ¼ 50%. With this simple equation in mind, bedside estimates of the clinical effect of diuresis, PEEP, and other treatment strategies on shunt fraction becomes very straightforward.
LIMITATIONS
In view of the above features, S v O2 can be a valuable and readily accessible measure in managing critically ill patents where adequacy of tissue oxygenation is an issue. In this regard, S v O2 is superior to cardiac output measurements and indeed, can be used to estimate cardiac output using the Fick equation. However, when the clinical issue is cardiac function, then other approaches such as echocardiography are far superior to S v O2 . The ability of Scv O 2 measurements to estimate S v O2 is imperfect and depends on catheter placement, patient anatomy, and In this example, when the shunt fraction is 50%, half of every increase in S v O 2 will be reflected in Sao 2 . Thus, an increase (exaggerated in this example to illustrate the effect) of S v O 2 from 40% to 80% will increase Sao 2 from 70% to 90%. This increase in Sao 2 is clinically highly significant, since Sao 2 of 70% over the course of several hours results in hypoxic death even in healthy mammals (26) , while an Sao 2 of 90% is completely compatible with life. Figure 4 . The relationship between oxygen delivery and oxygen consumption is used to frame the interpretation of S v O 2 values using the further knowledge that S v O 2 z 1 2 ERO 2 . At rest in health, cardiac output may be approximately 5 L/min and oxygen-carrying capacity of fully saturated blood (Ca O 2 ) is approximately 200 ml O 2 /L of blood. Therefore, the amount of oxygen being delivered to the tissues is DO 2 ¼ cardiac output 3 Ca O 2 ¼ 5 3 200 ¼ 1,000 ml O 2 /min. At rest, whole body oxygen consumption (VO 2 ) is about 250 ml O 2 per minute. That is, about 25% of the oxygen delivery was consumed so that the oxygen extraction ratio is 25% and the remainder, S v O 2 , is 75% (assuming an arterial saturation of z 100%). If cardiac output or hemoglobin decrease, then DO 2 decreases but VO 2 will remain relatively constant, since basal metabolic rate at rest is relatively unchanged (flat portion of the relationship). ER necessarily increases. Since it is not possible to extract more oxygen than is delivered (VO 2 must be less than DO 2 ), it means that at some very low DO 2 , VO 2 must also decrease (down-sloping portion of the relationship). This is the onset of anaerobic metabolism characterized by a rising lactate and signs of shock and organ dysfunction.
physiologic state. This should always be kept in mind when interpreting Scv O 2 measurements. When a true mixed venous oxygen saturation is essential, pulmonary artery catheter placement is required.
Scv O 2 and S v O2 measurements should never be interpreted in isolation. Rather, clinical context must always be considered. For example, S v O2 over 70% is generally a good indicator. Yet in the setting of extreme vasodilatory shock or following mitochondrial poisoning where organ function is poor and lactate is rising, an S v O2 of 90% provides no comfort (14) . In these readily apparent clinical contexts, a high S v O2 suggests that tissue oxygen extraction capacity is severely impaired and/or regional tissue hypoxia (e.g., gut ischemia) is present.
Is it necessary to measure central venous oxygen saturation continuously using a fiberoptic catheter, or do intermittent measurements (e.g., blood samples) suffice? This depends on clinical context. In a setting in which clinically important minute-tominute changes that would otherwise go undetected are possible (e.g., specific operating room scenarios), then continuous measurement may be helpful. Baulig and coworkers report significant differences between continuous fiberoptic measurements and intermittent measurements (52) . This additional source of error must be considered when interpreting continuous measurements, and can be minimized by careful attention to drift and calibration issues of the continuous measurement instrument. In other settings in which changes over hours need to be identified, intermittent measurements are often sufficient. For intermediate time-course settings, such as rapid resuscitation of shock, either approach can be used successfully.
SUMMARY
When adequacy of tissue oxygenation is a key issue, the balance between oxygen delivery and oxygen consumption must be considered. S v O 2 reflects this balance directly while cardiac output does not. Therefore, S v O 2 may be a more informative clinical measure. ERO 2 crit, reflecting the onset of tissue hypoxia, is a well-understood and stable parameter. Since S v O 2 z 1 2 ERO 2 , this knowledge can be used to understand critical S v O 2 values. Scv O 2 plays a central role in EGDT protocols, which appear to greatly improve patient outcomes. In addition, S v O 2 is important in understanding arterial desaturation events; intimately linked to shunt fraction. Understanding the role of S v O 2 provides an additional (non-lung) degree of freedom when treating severe arterial hypoxemia. Measurements of Scv O 2 are often readily available, since a thoracic central line is often needed as part of care in critically ill patients. Attention to placement of the tip of the central line near or at the right atrium increases the accuracy of Scv O 2 in reflecting S v O 2 . Thoughtful measurement and interpretation of S v O 2 can contribute substantially to successful patient management.
